| Financial Year |
March 31 2023 |
| Monetary Funds |
102,662,217.58 |
| Held-for-trading Financial Assets |
7,049,309.17 |
| Notes Receivable |
-- |
| Accounts Receivable |
2,370,087.72 |
| Advances to Suppliers |
31,545.04 |
| Other Receivables |
15,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
174,230.95 |
| Total Current Assets |
112,302,390.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
17,482,631.97 |
| Investment Properties |
9,092,176.84 |
| Fixed Assetes |
369,526.29 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,996,790.90 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
33,883,983.04 |
| Total Assets |
146,186,373.50 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
3,398,951.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
-- |
| Taxes Payable |
7,301,545.28 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,462,891.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
76,476.20 |
| Other Current Liabilities |
474,380.06 |
| Sub-Total of Current Liabilities |
22,504,714.80 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
10,000.00 |
| Deferred Income Tax Liabilities |
1,027,276.13 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,232,981.08 |
| Total Liabilities |
23,737,695.88 |
| Paid-In Capital(Or Share Stock) |
181,500,000.00 |
| Capital Surplus |
68,377,253.34 |
| Surplus Reserve |
18,111,896.60 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-136,896,446.15 |
| Minority Stockholder's Interest |
3,395,168.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
119,053,508.65 |
| Owner's Equity（Stockholder's Equity） |
122,448,677.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
146,186,373.50 |
